5Sato A,Narukawa M.Investigation of the relationship between a starting dose in first-in-human studies and no observed adverse effect level in nonclinical studies[J].Int J Clin Pharmacol Ther,2014,52(9):770.
6Harrak M,Khabbal Y,Amarti A,et al.Pharmacogenetics and prediction of side effects of drugs[J].Ann Biol Clin(Paris),2014,72(4):405.
7L D. Rosca. Survey:calculation oi the characteristics of ond diffusion- controlled release dosage forms related to the drug[ J]. European jour- nal of dug metabolism and pharmacokinetics, 2010,35 ( 1/2 ) : 1201 - 1211.
